Marco Boorsma PhD
General Partner
Development of gene therapy targeting mucosal tissues, including those of the bladder, lung and gut.
Gene delivery to mucosal tissues allows for the treatment of a wide range of diseases. enGene’s lead program is an immune-oncology gene therapy for treatment of non-muscle invasive bladder cancer, and has other programs in gene delivery to the lung and gut.
enGene is based in Montreal with management and clinical operations in Boston.
Industry
Biotech
Status
Current
Location
Canada
Forbion team
Mathias Vinther PhD
Principal